Personalised Prevention of Microbiological Homeostasis in the Oral Cavity During Fixed Orthodontic Treatment
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · Dec 20, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how personalized prevention strategies can help maintain a healthy balance of bacteria in the mouth during orthodontic treatment, such as braces. When patients wear braces, it can be harder to keep their teeth clean, leading to an imbalance of bacteria, known as dysbiosis. The trial will involve two groups: one will receive personalized prevention strategies tailored to their specific needs, while the other will follow standard care without these personalized measures. The goal is to see if the personalized approach can help prevent dysbiosis and keep the mouth healthier throughout treatment.
To participate, patients must be between 12 and 20 years old and need fixed orthodontic treatment (like braces). However, individuals with certain conditions, such as untreated cavities or weakened immune systems, cannot join. If selected for the trial, participants can expect regular check-ups and personalized advice on how to maintain their oral health during their orthodontic treatment. This study aims to create better prevention strategies that could eventually benefit all patients undergoing orthodontic care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 12 to 20 (permanent dentition) requiring fixed orthodontic treatment.
- Exclusion Criteria:
- • Tobacco;
- • Overcrowded restorations, untreated caries,
- • lack of tooth mineralisation;
- • Medical pathologies;
- • Known immunodepression (congenital or acquired);
- • Taking a treatment that may induce general immunodepression;
- • Taking a probiotic;
- • Taking a concomitant treatment that may interact with oral health
About Centre Hospitalier Universitaire De Nice
The Centre Hospitalier Universitaire (CHU) de Nice is a leading academic medical center located in Nice, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Nice is committed to enhancing patient care by conducting rigorous studies that explore new therapies and treatment modalities across various medical disciplines. With a focus on collaboration, the center integrates cutting-edge technology and interdisciplinary expertise to ensure the highest standards of research integrity and patient safety. CHU de Nice plays a vital role in the development of evidence-based medicine, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nice, , France
Dinan, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported